Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.24 USD | +0.66% | -1.01% | -13.97% |
05-14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
05-03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.97% | 3.4B | |
+7.51% | 111B | |
+11.31% | 106B | |
-12.55% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.78% | 16.81B | |
+37.29% | 12.54B | |
-24.05% | 8.09B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Sector Update: Health Care Stocks Higher Friday Afternoon